TNF and metabolic dysfunction-associated steatotic liver disease: In our study, GO and KEGG pathway enrichment analysis of DEOSGs in HCC patients also indicated that DEOSGs were mainly involved in MAPK/TNF signaling pathway, chemical carcinogenesis, hepatitis B and nonalcoholic fatty liver disease (Supplementary Figure S1).